Literature DB >> 32717427

Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.

Peter G E Kennedy1, Michael W Graner2, Deandra Walker3, Tiffany Pointon3, Anthony Fringuello2, Xiaoli Yu4.   

Abstract

Oligoclonal bands and increased IgG antibody levels can be detected in the cerebrospinal fluid in vast majority of patients with Multiple Sclerosis (MS). However, the antigenic specificity of oligoclonal IgG has yet to be determined. Using laser capture microdissection, we isolated single CD38+ plasma cells from lesion areas in two autopsy MS brains, and generated three recombinant antibodies (rAbs) from clonally expanded plasma cells. Panning phage-displayed random peptide libraries was carried out to determine peptide antigen specificities of these MS brain rAbs. We identified 25 high affinity phage peptides from which 5 peptides are unique. Database searches revealed that they shared sequence homologies with Epstein-Barr nuclear antigens 4 and 6, as well as with other viral proteins. Significantly, these peptides were recognized by intrathecal IgG and oligoclonal IgG bands in other MS patients. Our results demonstrate that functional recombinant antibodies can be generated from clonally expanded plasma cells in MS brain lesions by laser capture microdissection, and that these MS brain rAbs have the potential for determining the targets of intrathecal IgG and oligoclonal bands.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid (CSF); IgG; Intrathecal antibody; Laser capture microdissection; Lesion; Multiple sclerosis; Oligoclonal bands; Peptide; Phage display; Recombinant antibody

Year:  2020        PMID: 32717427     DOI: 10.1016/j.jneuroim.2020.577319

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  1 in total

1.  Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis.

Authors:  Peter G E Kennedy; Michael Graner; Tiffany Pointon; Xiaomeng Li; Kayo Tanimoto; Kathryn Dennison; Gina Im; Anthony Fringuello; Wenbo Zhou; Arin Graner; Stefan Sillau; Timothy Vollmer; Xiaoli Yu
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-03       Impact factor: 7.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.